PL344573A1 - Novel formulation containing paroxetine - Google Patents

Novel formulation containing paroxetine

Info

Publication number
PL344573A1
PL344573A1 PL99344573A PL34457399A PL344573A1 PL 344573 A1 PL344573 A1 PL 344573A1 PL 99344573 A PL99344573 A PL 99344573A PL 34457399 A PL34457399 A PL 34457399A PL 344573 A1 PL344573 A1 PL 344573A1
Authority
PL
Poland
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
novel
Prior art date
Application number
PL99344573A
Other languages
English (en)
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL344573A1 publication Critical patent/PL344573A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL99344573A 1998-05-13 1999-05-13 Novel formulation containing paroxetine PL344573A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
PL344573A1 true PL344573A1 (en) 2001-11-05

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99344573A PL344573A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (id)
JP (1) JP2002514591A (id)
KR (1) KR20010043574A (id)
CN (1) CN1308521A (id)
AP (1) AP2000002019A0 (id)
AU (1) AU3940999A (id)
BG (1) BG105010A (id)
BR (1) BR9910401A (id)
CA (1) CA2331871A1 (id)
EA (1) EA200001174A1 (id)
GB (1) GB9810181D0 (id)
HU (1) HUP0102064A2 (id)
ID (1) ID28019A (id)
IL (1) IL139594A0 (id)
NO (1) NO20005683L (id)
PL (1) PL344573A1 (id)
SK (1) SK17142000A3 (id)
TR (1) TR200003350T2 (id)
WO (1) WO1999058113A2 (id)
ZA (1) ZA200006562B (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
WO2003044012A1 (en) * 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2001508460A (ja) * 1997-01-15 2001-06-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー パロキセチン組成物
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida

Also Published As

Publication number Publication date
TR200003350T2 (tr) 2001-03-21
EP1077682A2 (en) 2001-02-28
NO20005683D0 (no) 2000-11-10
GB9810181D0 (en) 1998-07-08
EA200001174A1 (ru) 2001-06-25
AU3940999A (en) 1999-11-29
BG105010A (en) 2001-07-31
JP2002514591A (ja) 2002-05-21
CA2331871A1 (en) 1999-11-18
KR20010043574A (ko) 2001-05-25
ZA200006562B (en) 2002-02-13
AP2000002019A0 (en) 2000-12-31
IL139594A0 (en) 2002-02-10
HUP0102064A2 (hu) 2002-05-29
ID28019A (id) 2001-05-03
CN1308521A (zh) 2001-08-15
WO1999058113A3 (en) 2000-02-17
WO1999058113A2 (en) 1999-11-18
NO20005683L (no) 2000-12-05
BR9910401A (pt) 2001-01-09
SK17142000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
EP1016400A4 (en) COMPOSITION FOR EXTERNAL USE
GB9809058D0 (en) Composition
PT1466615E (pt) Composição farmacêutica
PL343769A1 (en) Pharmaceutical composition
GB9818591D0 (en) Pharmaceutical composition
GB9812119D0 (en) Composition
PL334568A1 (en) Paroxetin containing compositions
GB9806788D0 (en) Composition
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
HUP0100580A3 (en) Formulations comprising dissolved paroxetine
GB9806793D0 (en) Composition
GB2331703B (en) Disinfectant compositions
PL344872A1 (en) Novel formulation containing paroxetine
PL344137A1 (en) Novel composition
IL138478A0 (en) Paroxetine compositions
IL139594A0 (en) Novel formulation containing paroxetine
GB9904523D0 (en) Platinum (11) compounds
GB9804041D0 (en) Composition
HU9800078D0 (en) Pharmaceutical composition
GB9806791D0 (en) Composition
HK1034904A (en) Novel formulation containing paroxetine
HK1034905A (en) Novel formulation containing paroxetine
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation